Literature DB >> 25627931

Glucocorticoid receptor function in health and disease.

Giorgio Caratti1, Laura Matthews1, Toryn Poolman1, Stephen Kershaw2, Matthew Baxter1, David Ray1.   

Abstract

Glucocorticoid hormones are essential for life in vertebrates. They act through the glucocorticoid receptor (GR), which is expressed in virtually all cells of the human body. Yet the actions of glucocorticoids (GCs) are specific to particular cell types. Broadly GCs regulate carbohydrate metabolism, inflammation, stress and cell fate. Synthetic GCs are widely used in medicine and are by far the most frequent cause of Cushing's syndrome in routine practice. The advent of novel drugs targeting the GR offers new opportunities to treat patients with immune, or malignant disease, and may also offer new opportunities to manage patients with adrenal insufficiency also. This review covers the latest understanding of how GCs work, how their actions are affected by disease, and where the new drugs may take us.
© 2015 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25627931     DOI: 10.1111/cen.12728

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  19 in total

Review 1.  The FKBP51 Glucocorticoid Receptor Co-Chaperone: Regulation, Function, and Implications in Health and Disease.

Authors:  Gabriel R Fries; Nils C Gassen; Theo Rein
Journal:  Int J Mol Sci       Date:  2017-12-05       Impact factor: 5.923

2.  Parental investment matters for maternal and offspring immune defense in the mouthbrooding cichlid Astatotilapia burtoni.

Authors:  Isabel S Keller; Walter Salzburger; Olivia Roth
Journal:  BMC Evol Biol       Date:  2017-12-20       Impact factor: 3.260

3.  BclI polymorphism of the glucocorticoid receptor and adrenal crisis in primary adrenal insufficiency.

Authors:  Kathrin Zopf; Kathrin R Frey; Tina Kienitz; Manfred Ventz; Britta Bauer; Marcus Quinkler
Journal:  Endocr Connect       Date:  2017-09-27       Impact factor: 3.335

Review 4.  Glucocorticoid receptor action in metabolic and neuronal function.

Authors:  Michael J Garabedian; Charles A Harris; Freddy Jeanneteau
Journal:  F1000Res       Date:  2017-07-24

5.  Improvement of dexamethasone sensitivity by chelation of intracellular Ca2+ in pediatric acute lymphoblastic leukemia cells through the prosurvival kinase ERK1/2 deactivation.

Authors:  Souleymane Abdoul-Azize; Isabelle Dubus; Jean-Pierre Vannier
Journal:  Oncotarget       Date:  2017-04-18

6.  Antibody-Directed Glucocorticoid Targeting to CD163 in M2-type Macrophages Attenuates Fructose-Induced Liver Inflammatory Changes.

Authors:  Pia Svendsen; Jonas H Graversen; Anders Etzerodt; Henrik Hager; Rasmus Røge; Henning Grønbæk; Erik I Christensen; Holger J Møller; Hendrik Vilstrup; Søren K Moestrup
Journal:  Mol Ther Methods Clin Dev       Date:  2016-12-24       Impact factor: 6.698

7.  Metabolomics Based Profiling of Dexamethasone Side Effects in Rats.

Authors:  Abeer K Malkawi; Karem H Alzoubi; Minnie Jacob; Goran Matic; Asmaa Ali; Achraf Al Faraj; Falah Almuhanna; Majed Dasouki; Anas M Abdel Rahman
Journal:  Front Pharmacol       Date:  2018-02-16       Impact factor: 5.810

8.  Glucocorticoid receptor mutations and clinical sensitivity to glucocorticoid in Chinese multiple sclerosis patients.

Authors:  Tian Song; Haoxiao Chang; Li Du; Linlin Yin; Fudong Shi; Xinghu Zhang
Journal:  Neurol Sci       Date:  2020-04-10       Impact factor: 3.307

Review 9.  Circadian rhythms in innate immunity and stress responses.

Authors:  Matthew Baxter; David W Ray
Journal:  Immunology       Date:  2020-01-03       Impact factor: 7.215

Review 10.  Drugs from nature targeting inflammation (DNTI): a successful Austrian interdisciplinary network project.

Authors:  Birgit Waltenberger; Atanas G Atanasov; Elke H Heiss; David Bernhard; Judith M Rollinger; Johannes M Breuss; Daniela Schuster; Rudolf Bauer; Brigitte Kopp; Chlodwig Franz; Valery Bochkov; Marko D Mihovilovic; Verena M Dirsch; Hermann Stuppner
Journal:  Monatsh Chem       Date:  2016-02-25       Impact factor: 1.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.